ArTara Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
33.75
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.76
|
-0.68
|
0.08
|
10.53%
|
|
2022-06-30
|
-0.94
|
-0.80
|
0.14
|
14.89%
|
|
2022-03-31
|
-0.90
|
-0.96
|
-0.06
|
-6.67%
|
|
2021-12-31
|
-0.94
|
-0.91
|
0.03
|
3.19%
|
|
2021-09-30
|
-1.01
|
-0.96
|
0.05
|
4.95%
|
|
2021-06-30
|
-1.05
|
-1.14
|
-0.09
|
-8.57%
|
|
2021-03-31
|
-0.73
|
-1.20
|
-0.47
|
-64.38%
|
|
2020-12-31
|
-0.54
|
-0.44
|
0.10
|
18.52%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.44
|
|
2021-12-31
|
-4.21
|
|
2020-12-31
|
-4.73
|
|
2019-12-31
|
-30.15
|
|
2018-12-31
|
-45.60
|
|
2017-12-31
|
-14.20
|
|
2016-12-31
|
-1.73
|
|
2015-12-31
|
-1.31
|
|
2014-12-31
|
-31.27
|